Table 4 Outcomes by treatment received.

From: Use of PEG-asparaginase in newly diagnosed adults with standard-risk acute lymphoblastic leukemia compared with E. coli-asparaginase: a retrospective single-center study

 

E. coli-asparaginase (n = 50)

PEG-asparaginase (n = 72)

P

CR on day 14, n (%)

22 (44.0)

48 (66.7)

0.016

Relapse, n (%)

22 (44.0)

33 (45.8)

0.856

5-year EFS rate (%)

43.6

46.9

0.632

5-year OS rate (%)

46.2

48.1

0.769

  1. Abbreviations: E. coli-asparaginase, Escherichia coli asparaginase; PEG-asparaginase, polyethylene glycol-conjugated asparaginase; CR, complete remission; EFS, event-free survival; OS, overall survival.
Back to article page